Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for prevention of facial paralysis after cerebellopontine angle/internal auditory canal tumor surgery
2006-005658-66Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylprednisolone sodium succinate in facial palsy (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Incidence of facial paralysis at day 8. Started Dec 2006; status: active.
02
Drugs
methylprednisolone sodium succinate
03
Conditions
facial palsy
Beyond the preview
Go deeper on 2006-005658-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005658-66.